Europe — EMA
Novalgine I.M./I.V. (Metamizole Sodium Monohydrate)
GNH USA supplies Novalgine I.M./I.V. (Metamizole sodium monohydrate), a pyrazolone analgesic for pain relief and fever reduction.
Request sourcing
What is Metamizole Sodium Monohydrate?
Metamizole sodium monohydrate, the active ingredient in Novalgine I.M./I.V., is a pyrazolone analgesic presented as an injectable solution for intramuscular and intravenous use. It provides pain relief and fever reduction in adult patients.
GNH USA supplies Novalgine I.M./I.V. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics and procurement agencies worldwide. The company follows EU GMP standards and provides full regulatory documentation for global distribution.
What is Metamizole Sodium Monohydrate used for?
Novalgine (metamizole sodium monohydrate) is used in the management of acute pain and fever, acting as an analgesic and antipyretic.
- Postoperative pain: provides effective analgesia after surgical procedures. - Acute musculoskeletal pain: reduces pain intensity in injuries or strains. - Fever: lowers elevated body temperature in adults. - Renal colic: alleviates severe flank pain associated with kidney stones. - Cancer‑related breakthrough pain: offers supplemental analgesia for uncontrolled pain episodes.
What are the side effects of Metamizole Sodium Monohydrate?
Novalgine may cause a range of adverse reactions, from mild to severe. Patients should be monitored for any unexpected symptoms during therapy.
Common Side Effects: - Injection site pain - Nausea - Vomiting - Transient hypotension
Serious or Rare Side Effects: - Agranulocytosis (dangerously low white‑blood‑cell count) - Severe skin reactions such as Stevens‑Johnson syndrome - Anaphylactic shock - Other blood dyscrasias
What precautions apply to Metamizole Sodium Monohydrate?
Before using Novalgine, clinicians should consider several safety factors to minimize risk.
- Renal impairment: monitor kidney function and adjust use accordingly. - Hepatic disease: use with caution in patients with liver dysfunction. - History of blood disorders: avoid in individuals with prior agranulocytosis or severe leukopenia. - Concurrent use of other pyrazolones: contraindicated due to additive toxicity. - Pregnancy and lactation: safety not established; avoid unless clearly needed. - Store at ambient temperature: keep in original container, protect from light and moisture.
What does Metamizole Sodium Monohydrate interact with?
Novalgine can interact with other medicines, requiring attention to avoid harmful effects.
Major Interactions (Avoid): - Concurrent use with other myelosuppressive agents: increased risk of severe neutropenia. - Combination with sulfonamides: heightened chance of blood dyscrasias.
Moderate Interactions (Monitor Closely): - Co‑administration with anticoagulants: may enhance bleeding tendency. - Use with NSAIDs: additive gastrointestinal irritation. - Interaction with ACE inhibitors: possible reduction in antihypertensive effect.



